Interleukin-1 Receptor-Like 1 Protein
"Interleukin-1 Receptor-Like 1 Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A receptor for INTERLEUKIN-33 that is related structurally to the interleukin-1 receptor. It contains three extracellular IMMUNOGLOBULIN-LIKE DOMAIN regions and associates with INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN upon binding IL-33 to initiate signaling. It may function in the response of HELPER T CELLS to INFLAMMATION.
| Descriptor ID |
D000072179
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.300.375
|
| Concept/Terms |
Interleukin-1 Receptor-Like 1 Protein- Interleukin-1 Receptor-Like 1 Protein
- Interleukin 1 Receptor Like 1 Protein
- Interleukin 1 Receptor-Related Protein
- Interleukin 1 Receptor Related Protein
- Interleukin-33 Receptor
- Interleukin 33 Receptor
- Receptor, Interleukin-33
- IL1RL1 Protein
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-1 Receptor-Like 1 Protein".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-1 Receptor-Like 1 Protein".
This graph shows the total number of publications written about "Interleukin-1 Receptor-Like 1 Protein" by people in this website by year, and whether "Interleukin-1 Receptor-Like 1 Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2013 | 0 | 4 | 4 |
| 2015 | 0 | 1 | 1 |
| 2016 | 3 | 0 | 3 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 1 | 3 |
| 2022 | 1 | 1 | 2 |
| 2023 | 0 | 1 | 1 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-1 Receptor-Like 1 Protein" by people in Profiles.
-
Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years. Blood Adv. 2026 Jan 13; 10(1):168-180.
-
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study. Bone Marrow Transplant. 2024 03; 59(3):334-343.
-
Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantation. JCI Insight. 2023 05 22; 8(10).
-
MAF1, a repressor of RNA polymerase III-dependent transcription, regulates bone mass. Elife. 2022 05 25; 11.
-
Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma. Clin Cancer Res. 2022 Mar 01; 28(5):972-983.
-
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat Metab. 2020 10; 2(10):1135-1148.
-
IL-33/ST2/IL-9/IL-9R signaling disrupts ocular surface barrier in allergic inflammation. Mucosal Immunol. 2020 11; 13(6):919-930.
-
Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups. Blood. 2020 04 23; 135(17):1428-1437.
-
sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure. Acta Cardiol. 2020 Dec; 75(8):739-747.
-
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD. Blood. 2018 06 21; 131(25):2846-2855.